Defining the dosage units for colistin methanesulfonate: Urgent need for international harmonization [2]

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 12, 2006, Pages 4231-

  Li, Jian ^a   Nation, Roger L ^a   Turnidge, John D ^b  

^a MONASH UNIVERSITY   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE;

ANTIBIOTIC THERAPY; DRUG FORMULATION; DRUG LABELING; EUROPE; GRAM NEGATIVE INFECTION; KIDNEY FUNCTION; LETTER; PRIORITY JOURNAL; UNITED STATES;

ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; COLISTIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG LABELING; HUMANS; INTERNATIONAL COOPERATION; SULFONIC ACIDS;

EID: 33845241673     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00756-06     Document Type: Letter

References (8)

1. Bergen, P. J., J. Li, C. R. Rayner, and R. L. Nation. 2006. Colistin methane-sulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1953-1958.
2. Falagas, M. E., and S. K. Kasiakou. 2006. Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world. Antimicrob. Agents Chemother. 50:2274-2275.
3. Forest Laboratories UK Limited. 2004. Colomycin injection - summary of product characteristics. Forest Laboratories UK Limited, Kent, United Kingdom.
4. Infectious Diseases Society of America. 2004. Bad bugs, no drugs. [Online.] http://www.idsociety.org/pa/IDSA_Paper4_final_web.pdf.
5. Li, J., R. L. Nation, R. W. Milne, J. D. Turnidge, and K. Coulthard. 2005. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int. J. Antimicrob. Agents 25:11-25.
6. Li, J., R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard, C. R. Rayner, and D. L. Paterson. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
7. Monarch Pharmaceuticals. 2005. Coly-Mycin M parenteral - package insert. Monarch Pharmaceuticals, Bristol, Tenn.
8. Talbot, G. H., J. Bradley, J. E. Edwards, Jr., D. Gilbert, M. Scheld, and J. G. Bartlett. 2006. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42:657-668.